Mitochondrial DNA sequence variation in Finnish patients with matrilineal diabetes mellitus

BMC Research Notes

Kari Majamaa¹  Saara Finnila²  Jukka S Moilanen³  Heidi K Soini¹ 

[1] Clinical Research Center, Oulu University Hospital, University of Oulu, P.O. Box 5000, FI-90014, Oulu, Finland;Institute of Clinical Medicine, Department of Neurology, University of Oulu, P.O. Box 5000, FI-90014, Oulu, Finland;Institute of Clinical Medicine, Department of Clinical Genetics, University of Oulu, P.O. Box 5000, FI-90014, Oulu, Finland

关键词: Maternal inheritance;    C;    m.16189 T>;    Mitochondrial DNA haplogroups;    diabetes;    Mitochondrial DNA;   

Others  :  1166157
DOI  :  10.1186/1756-0500-5-350

 received in 2012-04-02, accepted in 2012-06-23,  发布年份 2012

【 摘 要 】

Background

The genetic background of type 2 diabetes is complex involving contribution by both nuclear and mitochondrial genes. There is an excess of maternal inheritance in patients with type 2 diabetes and, furthermore, diabetes is a common symptom in patients with mutations in mitochondrial DNA (mtDNA). Polymorphisms in mtDNA have been reported to act as risk factors in several complex diseases.

Findings

We examined the nucleotide variation in complete mtDNA sequences of 64 Finnish patients with matrilineal diabetes. We used conformation sensitive gel electrophoresis and sequencing to detect sequence variation. We analysed the pathogenic potential of nonsynonymous variants detected in the sequences and examined the role of the m.16189 T>C variant. Controls consisted of non-diabetic subjects ascertained in the same population. The frequency of mtDNA haplogroup V was 3-fold higher in patients with diabetes. Patients harboured many nonsynonymous mtDNA substitutions that were predicted to be possibly or probably damaging. Furthermore, a novel m.13762 T>G in MTND5 leading to p.Ser476Ala and several rare mtDNA variants were found. Haplogroup H1b harbouring m.16189 T > C and m.3010 G > A was found to be more frequent in patients with diabetes than in controls.

Conclusions

Mildly deleterious nonsynonymous mtDNA variants and rare population-specific haplotypes constitute genetic risk factors for maternally inherited diabetes.

【 授权许可】

   
2012 Soini et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]DiMauro S, Schon EA: Mitochondrial respiratory-chain diseases. N Engl J Med 2003, 348:2656-2668.
• [2]Ylikallio E, Suomalainen A: Mechanisms of mitochondrial diseases. Ann Med 2011, 1:19. online article http://informahealthcare.com/doi/abs/10.3109/07853890.2011.598547 webcite
• [3]Finnilä S, Lehtonen MS, Majamaa K: Phylogenetic network of European mtDNA. Am J Hum Genet 2001, 68:1475-1484.
• [4]Niemi AK, Hervonen A, Hurme M, Karhunen PJ, Jylhä M, Majamaa K: Mitochondrial DNA polymorphisms associated with longevity in a Finnish population. Hum Genet 2003, 112:29-33.
• [5]Lenaz G, Genova ML: Structural and functional organization of the mitochondrial respiratory chain: a dynamic super-assembly. Int J Biochem Cell Biol 2009, 10:1750-1772.
• [6]Lenaz G, Mörl M, Florentz C: Mitochondrial tRNA 3’ end metabolism and disease. Nucleic Acids Res 2004, 32:5430-5441.
• [7]Moilanen JS, Majamaa K: Phylogenetic network and physicochemical properties of nonsynonymous mutations in the protein-coding genes of human mitochondrial DNA. Mol Biol Evol 2003, 20:1195-1210.
• [8]Achilli A, Olivieri A, Pala M, Kashani BH, Carossa V, Perego UA, Gandifi F, Santoro A, Battaglia V, Grugni V, Lancioni H, Sirolla C, Bonfigli AR, Cormio A, Boemi M, Testa I, Semino O, Ceriello A, Spazzafumo L, Gadaleta MN, Marra M, Testa R, Franceschi C, Torroni A: Mitochondrial DNA backgrounds might modulate diabetes complications rather than T2DM as a whole. PLoS One 2011, 6:e21029.
• [9]Moilanen JS, Finnilä S, Majamaa K: Lineage-specific selection in human mtDNA: lack of polymorphisms in a segment of MTND5 gene in haplogroup J. Mol Biol Evol 2003, 20:2132-2142.
• [10]Elson JL, Turnbull DM, Howell N: Comparative genomics and the evolution of human mitochondrial DNA: assessing the effects of selection. Am J Hum Genet 2004, 74:229-238.
• [11]Alcolado JC, Laji K, Gill-Randall R: Maternal transmission of diabetes. Diabet Med 2002, 19:89-98.
• [12]Van den Ouweland JM, Lemkes HH, Trembath RC, Ross R, Velho G, Cohen D, Froguel P, Maassen JA: Maternally inherited diabetes and deafness is a distinct subtype of diabetes and associates with a single point mutation in the mitochondrial tRNA(Leu(UUR)) gene. Diabetes 1994, 43:746-751.
• [13]Majamaa K, Moilanen JS, Uimonen S, Remes AM, Salmela PI, Kärppä M, Majamaa-Voltti KA, Rusanen H, Sorri M, Peuhkurinen KJ, Hassinen IE: Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population. Am J Hum Genet 1998, 63:447-454.
• [14]Liou CW, Lin TK, Chen JB, Tiao MM, Weng SW, Chen SD, Chuang YC, Wang PW: Association between a common mitochondrial DNA D-loop polycytocine variant and alteration of mitochondrial copy number in human peripheral blood cells. J Med Genet 2010, 47:723-728.
• [15]Parker E, Phillips DI, Cockington RA, Cull C, Poulton J: A common mitochondrial DNA variant is associated with thinness in mothers and their 20-yr-old offspring. Am J Physiol Endocrinol Metab 2005, 6:1110-1114.
• [16]Casteels K, Ong K, Phillips D, Bendall H, Pembrey M: Mitochondrial 16189 variant, thinness at birth, and type-2 diabetes. Lancet 1999, 353:1499-1500.
• [17]Liou CW, Lin TK, Huei Weng H, Lee CF, Chen TL, Wei YH, Chen SD, Chuang YC, Weng SW, Wang PW: A common mitochondrial DNA variant and increased body mass index as associated factors for development of type 2 diabetes: Additive effects of genetic and environmental factors. J Clin Endocrinol Metab 2007, 92:235-239.
• [18]Poulton J, Luan J, Macaulay V, Hennings S, Mitchell J, Wareham NJ: Type 2 diabetes is associated with a common mitochondrial variant: evidence from a population-based case–control study. Hum Mol Genet 2002, 11:1581-1583.
• [19]Park KS, Chan JC, Chuang L-M, Suzuki S, Araki E, Nanjo K, Ji L, Ng M, Nishi M, Furuta H, Shirotani T, Ahn BY, Chung SS, Min H-K, Lee SW, Kim JH, Cho YM, Lee HK: A mitochondrial variant at position 16189 is associated with type 2 diabetes mellitus in Asians. Diabetologia 2008, 51:602-608.
• [20]Weng SW, Liou CW, Lin TK, Wei YH, Lee CF, Eng HL, Chen SD, Liu RT, Chen JF, Chen IY, Chen MH, Wang PW: Association of mitochondrial deoxyribonucleic acid 16189 variant (T > C transition) with metabolic syndrome in Chinese adults. J Clin Endocrinol Metab 2005, 90:5037-5040.
• [21]Van Esch A, Steyerberg EW, Berger MY, Offringa M, Derksen-Lubsen G, Habbema JDF: Family history and recurrence of febrile seizures. Arch Dis Child 1994, 70:395-399.
• [22]Meinilä M, Finnilä S, Majamaa K: Evidence for mtDNA admixture between the Finns and the Saami. Hum Hered 2001, 52:160-170.
• [23]Torroni A, Huoponen K, Francalacci P, Petrozzi M, Morelli L, Scozzari R, Obinu D, Savontaus ML, Wallace DC: Classification of European mtDNA’s from an analysis of three European populations. Genetics 1996, 144:1835-1850.
• [24]Finnilä S, Hassinen IE, Ala-Kokko L, Majamaa K: Phylogenetic network of the mtDNA haplogroup U in Northern Finland based on sequence analysis of the complete coding region by conformation-sensitive gel electrophoresis. Am J Hum Genet 2000, 66:1017-1026.
• [25]Körkkö J, Annunen S, Pihlajamaa T, Prockop DJ, Ala-Kokko L: Conformation sensitive gel electrophoresis for simple and accurate detection of mutations: comparison with denaturing gradient gel electrophoresis and nucleotide sequencing. Proc Natl Acad Sci USA 1998, 95:1681-1685.
• [26]Werle E, Schneider C, Renner M, Völker M, Fiehn W: Convenient single-step, one tube purification of PCR products for direct sequencing. Nucleic Acids Res 1994, 22:4354-4355.
• [27]Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, Turnbull DM, Howell N: Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet 1999, 23:147.
• [28]Tanaka M, Cabrera VM, Gonzalez AM, Larruga JM, Takeyasu T, Fuku N, Guo LJ, Hirose R, Fujita Y, Kurata M, Shinoda K, Umetsu K, Yamada Y, Oshida Y, Sato Y, Hattori N, Mizuno Y, Arai Y, Hirose N, Ohta S, Ogawa O, Tanaka Y, Kawamori R, Shamoto-Nagai M, Maruyama W, Shimokata H, Suzuki R, Shimodaira H: Mitochondrial genome variation in eastern Asia and the peopling of Japan. Genome Res 2004, 14(10A):1832-1850.
• [29]Ingman M, Gyllensten U: mtDB: Human Mitochondrial Genome Database, a resource for population genetics and medical sciences. Nucleic Acids Res 2006, 34:D749-D751.
• [30]Ruiz-Pesini E, Lott MT, Procaccio V, Poole JC, Brandon MC, Mishmar D, Yi C, Kreuziger J, Baldi P, Wallace DC: An enhanced MITOMAP with a global mtDNA mutational phylogeny. Nucleic Acids Res 2007, 35:D823-D828.
• [31]Pütz J, Dupuis B, Sissler M, Florentz C: Mamit-tRNA, a database of mammalian mitochondrial tRNA primary and secondary structures. RNA 2007, 13:1184-1190.
• [32]Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR: A method and server for predicting damaging missense mutations. Nat Methods 2010, 7:248-249.
• [33]Rost B, Yachdav G, Liu J: The PredictProtein Server. Nucleic Acids Res 2003, 32(Web Server issue):W321-W326.
• [34]Bandelt HJ, Forster P, Sykes BC, Richards MB: Mitochondrial portraits of human populations using median networks. Genetics 1995, 141:743-753.
• [35]Tambets K, Rootsi S, Kivisild T, Help H, Serk P, Loogväli EL, Tolk HV, Reidla M, Metspalu E, Pliss L, Balanovsky O, Pshenichnov A, Balanovska E, Gubina M, Zhadanov S, Osipova L, Damba L, Voevoda M, Kutuev I, Bermisheva M, Khusnutdinova E, Gusar V, Grechanina E, Parik J, Pennarun E, Richard C, Chaventre A, Moisan JP, Barac L, Pericic M, Rudan P, Terzic R, Mikerezi I, Krumina A, Baumanis V, Koziel S, Rickards O, De Stefano GS, Anagnou N, Pappa KI, Michalodimitrakis E, Ferak V, Furedi S, Komel R, Beckman L, Villems R: The western and eastern roots of the Saami—the story of genetic “outliers” told by mitochondrial DNA and Y choromosomes. Am J Hum Genet 2004, 74:661-682.
• [36]Ross AB, Johansson A, Ingman M, Gyllensten U: Lifestyle, genetics and disease in Sami. Croat Med J 2006, 47:553-565.
• [37]Palanichamy MG, Sun C, Agrawal S, Bandelt HJ, Kong QP, Khan F, Wang CY, Chaudhuri TK, Palla V, Zhang YP: Phylogeny of mitochondrial DNA macrohaplogroup N in India, based on complete sequencing: implications for the peopling of South Asia. Am J Hum Genet 2004, 75:966-978.
• [38]Kirches E, Winkler K, Vielhaber S, Michael M, Warich-Kirches M, von Bossanyi P, Plate I, Kunz WS, Szibor R, Feistner H, Dietzmann K: Mitochondrial tRNA(Cys) mutation A5823G in a patient with motor neuron disease and temporal lobe epilepsy. Pathobiology 1999, 67:214-218.
• [39]Levinger L, Mörl M, Florentz C: Mitochondrial tRNA 3’ end metabolism and disease. Nucleic Acids Res 2004, 32:5430-5441.
• [40]McFarland R, Elson JL, Taylor RW, Howell N, Turnbull DM: Assigning pathogenicity to mitochondrial tRNA mutations: when ‘definitely maybe’ is not good enough. Trends Genet 2004, 20:591-596.
• [41]Lehtonen MS, Moilanen JS, Majamaa K: Increased variation in mtDNA in patients with familial sensorineural hearing impairment. Hum Genet 2003, 113:220-227.
• [42]Khusnutdinova E, Gilyazova I, Ruiz-Pesini E, Derbeneva O, Khusainova R, Khidiyatova I, Magzhanov R, Wallace DC: A mitochondrial etiology of neurodegenerative diseases: evidence from Parkinson’s disease. Ann NY Acad Sci 2008, 1148:1-20.
• [43]Petros JA, Baumann AK, Ruiz-Pesini E, Amin MB, Sun CQ, Hall J, Lim S, Issa MM, Flanders WD, Hosseini SH, Marshall FF, Wallace DC: mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci USA 2005, 102:719-724.
• [44]Varlamov DA, Kudin AP, Vielhaber S, Schröder R, Sassen R, Becker A, Kunz D, Haug K, Rebstock J, Heils A, Elger CE, Kunz WS: Metabolic consequences of a novel missense mutation of the mtDNA CO I gene. Hum Mol Genet 2002, 11:1797-1805.
• [45]Herrnstadt C, Elson JL, Fahy E, Preston G, Turnbull DM, Anderson C, Ghosh SS, Olefsky JM, Beal MF, Davis RE, Howell N: Reduced-median-network analysis of complete mitochondrial DNA coding-region sequences for the major African, Asian, and European haplogroups. Am J Hum Genet 2002, 70:1152-1171.
• [46]Das S, Bennett AJ, Sovio U, Ruokonen A, Martikainen H, Pouta A, Hartikainen A-L, Franks S, Elliott P, Poulton J, Järvelin M-R, McCarthy MI: Detailed analysis of variation at and around mitochondrial position 16189 in a large Finnish cohort reveals no significant associations with early growth or metabolic phenotypes at age 31 years. J Clin Endocrinol Metab 2007, 92:3219-3223.
• [47]Mohlke KL, Jackson AU, Scott LJ, Peck EC, Suh YD, Chines PS, Watanabe RM, Buchanan TA, Conneely KN, Erdos MR, Narisu N, Enloe S, Valle TT, Tuomilehto J, Bergman RN, Boehnke M, Collins FS: Mitochondrial polymorphisms and susceptibility to type 2 diabetes –related traits in Finns. Hum Genet 2005, 118:245-254.
• [48]Loogväli E-L, Roostalu U, Malyarchuk BA, Derenko MV, Kivisild T, Metspalu E, Tambets K, Reidla M, Tolk H-V, Parik J, Pennarun E, Laos S, Lunkina A, Golubenko M, Barác L, Pericic M, Balanovsky OP, Gusar V, Khusnitdinova EK, Stepanov V, Puzyrev V, Rudan P, Balanovska EV, Grechanina E, Richard C, Moisan J-P, Chaventré A, Anagnou NP, Pappa KI, Michalodimitrakis EN, Claustres M, Gölge M, Mikerezi I, Usanga E, Villems R: Disuniting Uniformity: A pied cladistic canvas of mtDNA haplogroup H in Eurasia. Mol Biol Evol 2004, 21:2012-2021.
• [49]Nishigaki Y, Fuku N, Tanaka M: Mitochondrial haplogroups associated with lifestyle-related diseases and longevity in the Japanese population. Geriatr Gerontol Int 2010, 10:S221-S235.